期刊文献+

HIV-1 gp41 CHR肽CP621-652 N端功能氨基酸的鉴定及其与NHR多肽T21相互作用研究 被引量:1

Identification of functional amino acids of HIV-1 gp41 CHR peptide CP621-652 and interaction with NHR peptide T21
原文传递
导出
摘要 目的确定HIV-1 gp41 CHR肽CP621-652前7个氨基酸的作用以及CP621-652与NHR肽T21复合物的结构取向,为下一步HIV gp41靶点的新型融合抑制剂改造提供线索。方法合成7个丙氨酸(Ala)逐一替换CP621-652前7个氨基酸序列QIWNNMT的突变体,测定其对HIV-1病毒的抑制活性,应用圆二色谱、聚丙烯酰胺凝胶电泳及凝胶排阻测定CP621-652及突变体与gp41 NHR肽T21的相互作用,合成N端带有半胱氨酸的CP621-652、C端带有半胱氨酸的NHR肽T21及相应的同源二聚体,应用二硫键氧化折叠及平衡策略,分析CP621-652与T21复合物的结合取向。结果CP621-652前7个氨基酸的Q^(1)、W^(3)、M^(6)、T^(7)被Ala替换后活性降低,圆二色谱、聚丙烯酰胺凝胶电泳及凝胶排阻色谱显示,CP621-652及突变体与gp41 NHR肽T21存在相互作用,形成螺旋复合物。N端带有半胱氨酸的CP621-652、C端带有半胱氨酸的NHR肽T21折叠后主要形成异源二聚体。交换平衡实验显示,异源二聚体比同源二聚体稳定。结论Q^(1)、W^(3)、M^(6)、T^(7)是CP621-652的功能氨基酸,CP621-652与T21形成反平行螺旋结构。 Objective To determine the functional amino acids of the first seven amino acids of HIV-1 gp41 CHR peptide CP621-652 at N-terminus and the orientation of complex of CP621-652 and NHR peptide T21,and provide a clue for further modifications of novel HIV-1 gp41 fusion inhibitors.Methods Seven CP621-652 variants containing an alanine(Ala)substitution one by one for the first seven amine acids QIWNNMT were synthesized and their inhibitory activities against HIV-1 were determined.The interactions of CP621-652 variants with gp41 NHR-peptide T21 were determined by circular dichroism spectroscopy,electrophoresis and gel exclusion.The variants of CP621-652 and T21 modified by cysteine at N-or C-terminus and their dimers of disulfide bond were synthesized,the binding orientation of the complex of CP621-652 and T21 was analyzed by oxidative folding and equilibrium strategy.Results The replacement of Q^(1),W^(3),M^(6) and T^(7) by Ala resulted in significant decrease in fusion inhibitory activity.The results of circular dichroism spectroscopy,electrophoresis and gel exclusion chromatography showed that CP621-652 and its mutant interacted with T21 to form a helical complex.CP621-652 with cysteine at N-terminal and T21 with cysteine at C-terminal was folded to form a high ratio of heterodimers.The exchange equilibrium experiment showed that the heterodimers were more stable than the homodimers.Conclusion Q^(1),W^(3),M^(6) and T^(7) are the functional amino acids of CP621-652.CP621-652 and T21form antiparallel helical structures.
作者 赵志铭 王孝花 余硕 种辉辉 何玉先 彭圣明 戴秋云 ZHAO Zhi-ming;WANG Xiao-hua;YU Shuo;ZHONG Hui-hui;HE Yu-xian;PENG Sheng-ming;DAI Qiu-yun(College of Chemistry,Xiangtan University,Xiangtan,Hunan 411105,China;Institute of Biotechnology,Academy of Military Medical Sciences,Academy of Military Sciences,Beijing 100071,China;Institute of Pathogen Biology,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100050,China)
出处 《军事医学》 CAS 2022年第8期594-600,共7页 Military Medical Sciences
基金 国家自然科学基金(81072676)。
关键词 HIV-1 HIV包膜蛋白质gp41 抑制剂CP621-652 结构-活性关系 结构取向 HIV-1 HIV envelope protein gp41 inhibitor CP621-652 structure-activity relationship structure orientation
  • 相关文献

参考文献2

二级参考文献22

  • 1Turner BG,Summers MF. Structural biology of HIV[J].Journal of Molecular Biology,1999,(01):1-32.
  • 2Root MJ,Steger HK. HIV-1 gp41 as a target for viral entry inhibition[J].Current Pharmaceutical Design,2004,(15):1805-1825.
  • 3Eggink D,Berkhout B,Sanders RW. Inhibition of HIV-1 by fusion inhibitors[J].Current Pharmaceutical Design,2010,(33):3716-3728.
  • 4Liu S,Jing W,Jiang S. HIV gp41 C-terminal heptad repeat contains multifunctional domains.Relation to mechanisms of action of anti-HIV peptides[J].Journal of Biological Chemistry,2007,(13):9612-9620.
  • 5Lu M,Kim PS. A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein[J].Journal of Biomolecular Structure and Dynamics,1997,(03):465-471.
  • 6Wild C,Oas T,McDanal C. A synthetic peptide inhibitor of human immunodeficiency virus replication:correlation between solution structure and viral inhibition[J].Proceedings of the National Academy of Sciences(USA),1992,(21):10537-10541.
  • 7Leung MY,Cohen FS. Increasing hydrophobicity of residues in an anti-HIV-1 Env peptide synergistically improves potency[J].Biophysical Journal,2011,(08):1960-1968.
  • 8Ingallinella P,Bianchi E,Ladwa NA. Addition of a cho-lesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency[J].Proceedings of the National Academy of Sciences(USA),2009,(14):5801-5806.
  • 9Nishikawa H,Nakamura S,Kodama E. Electrostatically constrained[alpha]-helical peptide inhibits replication of HIV-1 resistant to enfuvirtide[J].International Journal of Biochemistry & Cell Biology,2009,(04):891-899.
  • 10Naito T,Izumi K,Kodama E. SC29EK,a peptide fusion inhibitor with enhanced alpha-helicity,inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtide[J].Antimicrobial Agents and Chemotherapy,2009,(03):1013-1018.

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部